EPISODE · Mar 27, 2024 · 27 MIN
New trials to address the anemia of lower-risk MDS [MDS Professional Report]
from כל תכני עושים היסטוריה · host רשת עושים היסטוריה
Drs Nikolaos Papadantonakis of Emory, Atlanta, US, and Moshe Mittelman, Tel-Aviv, Israel, discuss trials presented in American Society of Hematology (ASH) 2023 meeting. They provide some data on luspatercept, imetelstat, roxodustat and Ker-050.
What this episode covers
Drs Nikolaos Papadantonakis of Emory, Atlanta, US, and Moshe Mittelman, Tel-Aviv, Israel, discuss trials presented in American Society of Hematology (ASH) 2023 meeting. They provide some data on luspatercept, imetelstat, roxodustat and Ker-050.
NOW PLAYING
New trials to address the anemia of lower-risk MDS [MDS Professional Report]
No transcript for this episode yet
Similar Episodes
Jul 5, 2026 ·47m
Jul 2, 2026 ·49m
Jul 2, 2026 ·56m
Jul 1, 2026 ·40m
Jun 25, 2026 ·63m